Improving efficiency with evidence-based testing

We employ care-driven, clinically validated testing approaches to not only produce definitive diagnosis, but also identify at-risk patients who require early intervention or increased surveillance. Targeted testing incorporates next-generation sequencing and pharmacogenomic panels to accurately identify genetic variants across a spectrum of cardiac disease-associated genes, and provides detailed information on prognosis and treatment selection.  

Featured testing available through Mayo Clinic Laboratories:

FHRGP | Familial Hypercholesterolemia and Related Disorders Multi-Gene Panel, Next-Generation Sequencing, Varies

PGXQP | Focused Pharmacogenomics Panel, Varies

Featured testing available through American Hospital Dubai:

American Hospital Dubai testing is orderable as code ZW158, Miscellaneous American Hospital Dubai, in the testing catalog.

C-reactive protein (CRP)

CRP – High Sensitivity

Brain natriuretic peptide (BNP)

Lipid panel

Learn more about cardiology testing at Mayo Clinic Laboratories.

Contact us